mRNA-based therapies require efficient and selective delivery systems to advance clinical applications and overcome challenges posed by current formulations. Here, authors developed Discrete Immolative Guanidinium Transporters (DIGITs), chemically defined carriers that enable pHresponsive mRNA release with organ and reticulocyte selectivity, minimal toxicity, and scalable synthesis.
- Zhijian Li
- Aloysius Ee
- Paul A. Wender
